Cargando…

Immune Reconstitution Kinetics following Intentionally Induced Mixed Chimerism by Nonmyeloablative Transplantation

Establishing mixed chimerism is a promising approach for inducing donor-specific transplant tolerance. The establishment and maintenance of mixed chimerism may enable long-term engraftment of organ transplants while minimizing the use of immunosuppressants. Several protocols for inducing mixed chime...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Nayoun, Lee, Hyunji, Shin, Junghoon, Nam, Young-Sun, Im, Keon-Il, Lim, Jung-Yeon, Lee, Eun-Sol, Kang, Young-Nam, Park, Se-Ho, Cho, Seok-Goo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427480/ https://www.ncbi.nlm.nih.gov/pubmed/25961559 http://dx.doi.org/10.1371/journal.pone.0126318

Ejemplares similares

Enhanced immunoregulation of mesenchymal stem cells by IL-10-producing type 1 regulatory T cells in collagen-induced arthritis
por: Lim, Jung-Yeon, et al.
Publicado: (2016)

Adoptive Transfer of Treg Cells Combined with Mesenchymal Stem Cells Facilitates Repopulation of Endogenous Treg Cells in a Murine Acute GVHD Model
por: Lee, Eun-Sol, et al.
Publicado: (2015)

Third-party regulatory T cells prevent murine acute graft-versus-host disease
por: Lim, Jung-Yeon, et al.
Publicado: (2018)

BAFF blockade attenuates acute graft-versus-host disease directly via the dual regulation of T- and B-cell homeostasis
por: Jeon, Youngwoo, et al.
Publicado: (2022)

A nonmyeloablative chimeric mouse model accurately defines microglia and macrophage contribution in glioma
por: Yu, K., et al.
Publicado: (2018)

The Synergistic Immunoregulatory Effects of Culture-Expanded Mesenchymal Stromal Cells and CD4(+)25(+)Foxp3(+) Regulatory T Cells on Skin Allograft Rejection
por: Lee, Jung Ho, et al.
Publicado: (2013)

Human mesenchymal stem cells derived from umbilical cord and bone marrow exert immunomodulatory effects in different mechanisms
por: Song, Yunejin, et al.
Publicado: (2020)

Off-the-Shelf Partial HLA Matching SARS-CoV-2 Antigen Specific T Cell Therapy: A New Possibility for COVID-19 Treatment
por: Kim, Nayoun, et al.
Publicado: (2021)

Reconstitution of an Infectious Human Endogenous Retrovirus
por: Lee, Young Nam, et al.
Publicado: (2007)

Extension of Maximal Lifespan and High Bone Marrow Chimerism After Nonmyeloablative Syngeneic Transplantation of Bone Marrow From Young to Old Mice
por: Kovina, Marina V., et al.
Publicado: (2019)

Graft-versus-Leukemia Effect of Nonmyeloablative Stem Cell Transplantation
por: Imamura, Masahiro, et al.
Publicado: (2009)

Kinetics of IL-7 and IL-15 Levels after Allogeneic Peripheral Blood Stem Cell Transplantation following Nonmyeloablative Conditioning
por: De Bock, Muriel, et al.
Publicado: (2013)

What Role Is There for Antithymocyte Globulin in Allogeneic Nonmyeloablative Canine Hematopoietic Cell Transplantation?
por: Diaconescu, Razvan, et al.
Publicado: (2005)

Clinical applications of mesenchymal stem cells
por: Kim, Nayoun, et al.
Publicado: (2013)

New Strategies for Overcoming Limitations of Mesenchymal Stem Cell-Based Immune Modulation
por: Kim, Nayoun, et al.
Publicado: (2015)

Alternative approaches to preserve MSC progenitor potency
por: Kim, Nayoun, et al.
Publicado: (2017)

Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide
por: Munchel, Ashley, et al.
Publicado: (2011)

Evolution of Graves’ Disease during Immune Reconstitution following Nonmyeloablative Haploidentical Peripheral Blood Stem Cell Transplantation in a Boy Carrying Germline SAMD9L and FLT3 Variants
por: Ip, Peng Peng, et al.
Publicado: (2022)

High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation
por: Long-Boyle, Janel R, et al.
Publicado: (2010)

Nonmyeloablative Allogeneic Stem-Cell Transplantation for Metastatic Renal Cell Cancer: A Review and Update
por: Erotocritou, P., et al.
Publicado: (2006)

Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell disease
por: Chu, Yaya, et al.
Publicado: (2022)

Comprehensive Clinical Characterization of Decade-Long Survivors of Metastatic Breast Cancer
por: Shin, Junghoon, et al.
Publicado: (2023)

Graft-vs-tumor effect in patients with advanced nasopharyngeal cancer treated with nonmyeloablative allogeneic PBSC transplantation
por: Toh, H C, et al.
Publicado: (2011)

Anti-thymocyte globulin with CsA and MMF as GVHD prophylaxis in nonmyeloablative HLA-mismatched allogeneic HCT
por: van der Velden, Walter J. F. M., et al.
Publicado: (2021)

The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation
por: Kim, Eun-Jung, et al.
Publicado: (2013)

Refolded scFv Antibody Fragment against Myoglobin Shows Rapid Reaction Kinetics
por: Song, Hyung-Nam, et al.
Publicado: (2014)

Chimeric Adeno-Associated Virus-Mediated Cardiovascular Reprogramming for Ischemic Heart Disease
por: Yoo, So Young, et al.
Publicado: (2018)

Long-Term Breast Cancer Outcomes of Pregnancy-Associated Breast Cancer (PABC) in a Prospective Cohort
por: Jo, Hyunji, et al.
Publicado: (2022)

Administration of anti-HER2 antibody after nonmyeloablative allogeneic stem cell transplantation in metastatic breast cancer
por: Banna, G L, et al.
Publicado: (2006)

Small Split Doses of CD34(+) Peripheral Blood Stem Cells to Support Repeated Cycles of Nonmyeloablative Chemotherapy
por: Yankelevich, Maxim, et al.
Publicado: (2017)

Real World Experience of Second-Line Treatment Strategies after Palbociclib and Letrozole: Overall Survival in Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
por: Kim, Ji-Yeon, et al.
Publicado: (2023)

Mechanical and kinetic effects of shortened tropomyosin reconstituted into myofibrils
por: Siththanandan, V. B., et al.
Publicado: (2009)

High prevalence of potential drug interactions affecting mycophenolic acid pharmacokinetics in nonmyeloablative hematopoietic stem cell transplant recipients
por: Jaklič, Alenka, et al.
Publicado: (2013)

The safety and effectiveness of genetically corrected iPSCs derived from β-thalassaemia patients in nonmyeloablative β-thalassaemic mice
por: Xian, Yexing, et al.
Publicado: (2020)

Favorable outcomes with durable chimerism after hematopoietic cell transplantation using busulfan and fludarabine-based reduced-intensity conditioning for pediatric patients with hemophagocytic lymphohistiocytosis
por: Suh, Jin Kyung, et al.
Publicado: (2022)

ChimerDB—a knowledgebase for fusion sequences
por: Kim, Namshin, et al.
Publicado: (2006)

Factors influencing lymphocyte reconstitution after allogeneic hematopoietic stem cell transplantation in children
por: Bae, Keun Wook, et al.
Publicado: (2012)

Factors Influencing Purchase Intention for Low-Sodium and Low-Sugar Products
por: Park, Yeowoon, et al.
Publicado: (2020)

Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation
por: Kanda, Junya, et al.
Publicado: (2011)

Fludarabine and cyclophosphamide provides a nonmyeloablative alternative conditioning regimen with low transplant-related mortality and control of high risk disease
por: Paplham, Pamela, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8o2af6g4nlkrrtgsrcncftp3fr